SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

FDA clears Argus Cognitive autism diagnosis aid

The FDA cleared Argus Cognitive's Neurora, a Class II pediatric autism diagnosis aid for children ages 18 months through 12 years. The tool measures more than 100 vocal, facial and gaze biometrics from standard behavioral assessments.